Neonatal Sepsis at Neonatal Intensive Care Units in Ghana
1 other identifier
interventional
5,433
1 country
1
Brief Summary
Background: Neonatal sepsis is a major contributor to global under five mortality. In developing countries a major proportion of neonatal sepsis is thought to emanate from the healthcare setting, due to challenges in infection prevention practices. Aim: To study the epidemiology of neonatal sepsis and evaluate the effect of multimodal infection control interventions on the incidence of neonatal sepsis; and colonization by multidrug resistant Gram negative bacteria (MDRGNB). Methods: A controlled before and after interventional trial comprising a 7 month pre- intervention phase, 5 month intervention phase and 7 month post-intervention phase. Neonates admitted at the Neonatal Intensive Care Unit (NICU) at Korle-Bu Teaching Hospital (KBTH) will be enrolled prospectively and followed up for diagnosis of sepsis and outcome of admission. This will be used to describe the epidemiology of neonatal sepsis. Swabs will be collected from a subpopulation of included neonates at intervention site (KBTH) and control site (37 Military Hospital) NICUs to assess colonization of neonates with MDRGNB. Environmental swabs will be collected from surfaces at the NICU to assess MDRGNB contamination of the environment. The intervention comprises infection prevention strategies including implementation of the WHO multimodal hand hygiene strategy. The primary endpoint is incidence of neonatal sepsis. Expected Outcome: This study will contribute to improved infection prevention practices in the participating NICUs and highlight lessons which other national and regional NICUs may learn from.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Oct 2018
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2018
CompletedFirst Submitted
Initial submission to the registry
November 23, 2018
CompletedFirst Posted
Study publicly available on registry
November 28, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 30, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
September 30, 2019
CompletedOctober 11, 2021
October 1, 2021
12 months
November 23, 2018
October 8, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Incidence of neonatal sepsis
Incidence of neonatal sepsis including clinical cases treated as sepsis and cases of neonatal sepsis with confirmed bloodstream infections per 1000 admissions.
Post-intervention at 7 months
Secondary Outcomes (4)
Rate of hand hygiene compliance per opportunity
Post-intervention at 7 months
Rate of MDR Gram negative bacteria colonization among neonates
During intervention at 2 months and post-intervention at 7 months
Length of admission in days
Post-intervention at 7 months
All-cause mortality
Post-intervention at 7 months
Study Arms (2)
Standard of care
NO INTERVENTIONContinuously monitoring of neonatal sepsis under standard of care at one site
Hand hygiene
EXPERIMENTALThe WHO multimodal hand hygiene strategy is implemented at one site
Interventions
Comprises five essential elements; system change-availability of alcohol-based hand rub at the point of care and/ or access to safe continuous water supply and soap and towels; training and education of healthcare professionals; monitoring of hand hygiene practices and performance feedback; reminders in the workplace; and the creation of a hand hygiene safety culture with the participation of both individual healthcare workers and senior hospital managers.
Eligibility Criteria
You may qualify if:
- Admission NICU
- Birth weight ≥750 Grams
- ≤48 hours of age at time of enrolment
- Consent to participate obtained from legal guardian
You may not qualify if:
- Neonates with severe congenital malformations
- Neonates who have undergone surgical procedure
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Stephanie Bjerrumlead
- University of Copenhagencollaborator
- Korle-Bu Teaching Hospital, Accra, Ghanacollaborator
- Rigshospitalet, Denmarkcollaborator
- University of Ghanacollaborator
Study Sites (1)
Korle Bu Teaching Hospital
Accra, Ghana
Related Publications (1)
Labi AK, Enweronu-Laryea CC, Nartey ET, Bjerrum S, Ayibor PK, Andersen LP, Newman MJ, Kurtzhals JAL. Bloodstream Infections at Two Neonatal Intensive Care Units in Ghana: Multidrug Resistant Enterobacterales Undermine the Usefulness of Standard Antibiotic Regimes. Pediatr Infect Dis J. 2021 Dec 1;40(12):1115-1121. doi: 10.1097/INF.0000000000003284.
PMID: 34561387DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Appiah Korang Labi, MD
Department of Int. Health and Immunlogy Microbiology, University og Copenhagen
- STUDY DIRECTOR
Jørgen Kurtzhals, Professor
Department of Int. Health and Immunlogy Microbiology, University og Copenhagen
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- MD, PHD, postdoc
Study Record Dates
First Submitted
November 23, 2018
First Posted
November 28, 2018
Study Start
October 1, 2018
Primary Completion
September 30, 2019
Study Completion
September 30, 2019
Last Updated
October 11, 2021
Record last verified: 2021-10